» Articles » PMID: 15707489

Replicative Homeostasis: a Fundamental Mechanism Mediating Selective Viral Replication and Escape Mutation

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2005 Feb 15
PMID 15707489
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C (HCV), hepatitis B (HBV), the human immunodeficiency viruses (HIV), and other viruses that replicate via RNA intermediaries, cause an enormous burden of disease and premature death worldwide. These viruses circulate within infected hosts as vast populations of closely related, but genetically diverse, molecules known as "quasispecies". The mechanism(s) by which this extreme genetic and antigenic diversity is stably maintained are unclear, but are fundamental to understanding viral persistence and pathobiology. The persistence of HCV, an RNA virus, is especially problematic and HCV stability, maintained despite rapid genomic mutation, is highly paradoxical. This paper presents the hypothesis, and evidence, that viruses capable of persistent infection autoregulate replication and the likely mechanism mediating autoregulation - Replicative Homeostasis - is described. Replicative homeostasis causes formation of stable, but highly reactive, equilibria that drive quasispecies expansion and generates escape mutation. Replicative homeostasis explains both viral kinetics and the enigma of RNA quasispecies stability and provides a rational, mechanistic basis for all observed viral behaviours and host responses. More importantly, this paradigm has specific therapeutic implication and defines, precisely, new approaches to antiviral therapy. Replicative homeostasis may also modulate cellular gene expression.

Citing Articles

The prevalence of low-level viraemia and its association with virological failure in people living with HIV: a systematic review and meta-analysis.

Zhao S, Wang W, Li S, He J, Duan W, Fang Z Emerg Microbes Infect. 2024; 14(1):2447613.

PMID: 39727007 PMC: 11722027. DOI: 10.1080/22221751.2024.2447613.


Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.

Ngo-Giang-Huong N, Huynh T, Dagnra A, Toni T, Maiga A, Kania D J Antimicrob Chemother. 2018; 74(2):462-467.

PMID: 30418575 PMC: 6337899. DOI: 10.1093/jac/dky443.


The effects of hepatitis C virus core protein on the expression of miR-122 in vitro.

Li S, Xing X, Yang Q, Xu H, He J, Chen Z Virol J. 2013; 10:98.

PMID: 23537271 PMC: 3623887. DOI: 10.1186/1743-422X-10-98.


Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis C.

Hoefs J, Aulakh V, Ilagan B Dig Dis Sci. 2011; 57(1):243-9.

PMID: 22139019 DOI: 10.1007/s10620-011-1973-7.


Rapid evolution of pandemic noroviruses of the GII.4 lineage.

Bull R, Eden J, Rawlinson W, White P PLoS Pathog. 2010; 6(3):e1000831.

PMID: 20360972 PMC: 2847951. DOI: 10.1371/journal.ppat.1000831.


References
1.
Sallie R . Transcriptional homeostasis: a mechanism of protein quality control. Med Hypotheses. 2004; 63(2):232-4. DOI: 10.1016/j.mehy.2004.02.024. View

2.
Tonegawa S . Somatic generation of antibody diversity. Nature. 1983; 302(5909):575-81. DOI: 10.1038/302575a0. View

3.
Ahlquist P, Dasgupta R, Kaesberg P . Nucleotide sequence of the brome mosaic virus genome and its implications for viral replication. J Mol Biol. 1984; 172(4):369-83. DOI: 10.1016/s0022-2836(84)80012-1. View

4.
KIHO Y, Nishiguchi M . Unique nature of an attenuated strain of tobacco mosaic virus: autoregulation. Microbiol Immunol. 1984; 28(5):589-99. DOI: 10.1111/j.1348-0421.1984.tb00711.x. View

5.
Lok A, Lai C, Wu P, Leung E, Lam T . Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology. 1987; 92(6):1839-43. DOI: 10.1016/0016-5085(87)90613-5. View